Saxenda weight loss claims: what the studies actually show

What did @burdiexo actually say?

@burdiexo reported losing "12 kilos in a total in two and a half weeks" on Saxenda, finishing her first pen and starting her second. She also described significant side effects, including "a lot of reflux and a lot of bloating," and said she'd learned to avoid spicy foods to manage symptoms. The tone is enthusiastic, personal, and pretty relatable.

This is a classic GLP-1 journey update: big number, real side effects, dietary adjustments. Nothing here sounds fabricated. But the weight figure deserves a closer look, because 12kg in 2.5 weeks is a striking claim, and social media doesn't always distinguish between fat loss and water weight.

Does the science back this up?

Partially. Rapid early weight loss on liraglutide (Saxenda's active ingredient) is real, but 12kg in 2.5 weeks is on the extreme end. The SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, NEJM) showed average weight loss of about 8.4kg over 56 weeks at the full 3mg dose. That's average, not maximum, and it doesn't account for the first few weeks of aggressive water weight loss many users experience when appetite drops sharply.

Water and glycogen depletion can account for 2-5kg in the first week alone when caloric intake drops substantially. So is 12kg biologically plausible? Possibly, if a significant chunk is fluid. Is it 12kg of fat? Almost certainly not. Fat loss at that rate would require a caloric deficit far beyond what's physiologically realistic, roughly 84,000 calories in 17 days.

• Pi-Sunyer et al., 2015 (NEJM): Mean fat mass reduction with liraglutide 3mg was gradual, not frontloaded.
• Gibson et al., 2015 (Obesity Reviews): Early weight loss on caloric restriction is predominantly water and glycogen.

What did they get wrong (or right)?

She got the side effects exactly right. Reflux and bloating are among the most commonly reported GI adverse effects with liraglutide. The SCALE trials consistently showed GI events in 60-70% of participants, particularly in the dose escalation phase. Her observation that dietary changes, specifically cutting spicy food, helped resolve symptoms is consistent with clinical guidance. GPs and dietitians routinely advise low-fat, low-spice diets during GLP-1 initiation.

Where she's misleading, probably without intending to be, is presenting 12kg as a simple, clean result without context. Viewers with different starting weights, doses, or metabolic profiles may expect the same outcome and feel like failures when they don't get it. The number itself isn't wrong, it's just missing the asterisk that early losses are disproportionately fluid, not fat.

She also doesn't mention she's still in dose escalation, which matters. Early Saxenda doses (0.6mg, 1.2mg) are starter doses, not therapeutic doses. Most clinical weight loss occurs at 3mg. Her results may look different once the dose stabilizes.

What should you actually know?

If you're watching this and thinking Saxenda will deliver 12kg in under three weeks, pump the brakes. Clinical trials suggest 5-10% body weight reduction over several months at the full dose, which is meaningful and significant for metabolic health, just not a TikTok highlight reel.

The GI side effects she describes are not a sign something is wrong. They're a known, expected pharmacological response. Liraglutide slows gastric emptying, which causes the bloating and reflux. Eating smaller meals, avoiding high-fat and spicy foods, and staying upright after eating are all evidence-backed ways to reduce these effects, exactly what she figured out through trial and error.

One thing worth adding: Saxenda requires a proper clinical assessment before starting. It's not appropriate for everyone, and the dose escalation schedule exists for a reason. Self-adjusting or skipping steps because results feel slow is a common mistake that worsens side effects without improving outcomes.

• Talk to a prescribing clinician if GI symptoms persist beyond the first few weeks.
• Weigh yourself consistently, same time, same conditions, to reduce noise in the numbers.
• Early dramatic losses almost always slow down. That's normal physiology, not failure.